Myeloperoxidase and N-terminal proatrial natriuretic peptide as predictors for atrial fibrillation recurrence in patients undergoing redo ablation.
Saved in:
| Title: | Myeloperoxidase and N-terminal proatrial natriuretic peptide as predictors for atrial fibrillation recurrence in patients undergoing redo ablation. |
|---|---|
| Authors: | Bannehr M; Department of Cardiology, University Hospital Heart Centre Brandenburg, Brandenburg Medical School (MHB) Theodor Fontane, Bernau/Neuruppin, Germany.; Faculty of Health Sciences, Joint Faculty of the University of Potsdam, the Brandenburg Medical School Theodor Fontane, and the Brandenburg Technical University Cottbus-Senftenberg, Cottbus, Germany., Georgi C; Department of Cardiology, University Hospital Heart Centre Brandenburg, Brandenburg Medical School (MHB) Theodor Fontane, Bernau/Neuruppin, Germany.; Faculty of Health Sciences, Joint Faculty of the University of Potsdam, the Brandenburg Medical School Theodor Fontane, and the Brandenburg Technical University Cottbus-Senftenberg, Cottbus, Germany., Edlinger C; Department of Cardiology, University Hospital Heart Centre Brandenburg, Brandenburg Medical School (MHB) Theodor Fontane, Bernau/Neuruppin, Germany.; Faculty of Health Sciences, Joint Faculty of the University of Potsdam, the Brandenburg Medical School Theodor Fontane, and the Brandenburg Technical University Cottbus-Senftenberg, Cottbus, Germany.; Department of Cardiology, Clinic of Internal Medicine II, Paracelsus Medical University of Salzburg, Salzburg, Austria., Paar V; Department of Cardiology, Clinic of Internal Medicine II, Paracelsus Medical University of Salzburg, Salzburg, Austria., Jankowska P; Department of Cardiology, University Hospital Heart Centre Brandenburg, Brandenburg Medical School (MHB) Theodor Fontane, Bernau/Neuruppin, Germany.; Faculty of Health Sciences, Joint Faculty of the University of Potsdam, the Brandenburg Medical School Theodor Fontane, and the Brandenburg Technical University Cottbus-Senftenberg, Cottbus, Germany., Lichtenauer M; Department of Cardiology, Clinic of Internal Medicine II, Paracelsus Medical University of Salzburg, Salzburg, Austria., Haase-Fielitz A; Department of Cardiology, University Hospital Heart Centre Brandenburg, Brandenburg Medical School (MHB) Theodor Fontane, Bernau/Neuruppin, Germany.; Faculty of Health Sciences, Joint Faculty of the University of Potsdam, the Brandenburg Medical School Theodor Fontane, and the Brandenburg Technical University Cottbus-Senftenberg, Cottbus, Germany.; Institute of Social Medicine and Health System Research, Otto von Guericke University Magdeburg, Magdeburg, Germany., Seifert M; Department of Cardiology, University Hospital Heart Centre Brandenburg, Brandenburg Medical School (MHB) Theodor Fontane, Bernau/Neuruppin, Germany.; Faculty of Health Sciences, Joint Faculty of the University of Potsdam, the Brandenburg Medical School Theodor Fontane, and the Brandenburg Technical University Cottbus-Senftenberg, Cottbus, Germany., Butter C; Department of Cardiology, University Hospital Heart Centre Brandenburg, Brandenburg Medical School (MHB) Theodor Fontane, Bernau/Neuruppin, Germany.; Faculty of Health Sciences, Joint Faculty of the University of Potsdam, the Brandenburg Medical School Theodor Fontane, and the Brandenburg Technical University Cottbus-Senftenberg, Cottbus, Germany. |
| Source: | Heart rhythm O2 [Heart Rhythm O2] 2024 Sep 13; Vol. 5 (11), pp. 770-777. Date of Electronic Publication: 2024 Sep 13 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101768511 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-5018 (Electronic) Linking ISSN: 26665018 NLM ISO Abbreviation: Heart Rhythm O2 Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
